This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Weiqiang Cheng, PhD
principal scientist at Takeda


Weiqiang Cheng, Ph.D. is a principal scientist at Drug Product Development Department of Takeda, where he leads formulation development, drug product process development and characterization, and supports manufacturing and regulatory filing of investigational drug products from pre-clinical stage to commercialization. Additionally, he also supports drug product OOS and OOT root-cause investigation for both clinical and commercial products. Prior to Takeda, he supported process characterization and validation of commercial drug product manufacturing at Sanofi Genzyme. His expertise includes liquid and lyophilized product development, biophysical characterization, protein chemistry and assay development, etc.

Agenda Sessions

  • Impact of Surfactants on Product Stability, and its Implication on Specification